These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 18657508)

  • 21. Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα.
    Sim J; Sockolosky JT; Sangalang E; Izquierdo S; Pedersen D; Harriman W; Wibowo AS; Carter J; Madan A; Doyle L; Harrabi O; Kauder SE; Chen A; Kuo TC; Wan H; Pons J
    MAbs; 2019; 11(6):1036-1052. PubMed ID: 31257988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target.
    Barclay AN; Van den Berg TK
    Annu Rev Immunol; 2014; 32():25-50. PubMed ID: 24215318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide-mediated inhibition of neutrophil transmigration by blocking CD47 interactions with signal regulatory protein alpha.
    Liu Y; O'Connor MB; Mandell KJ; Zen K; Ullrich A; Bühring HJ; Parkos CA
    J Immunol; 2004 Feb; 172(4):2578-85. PubMed ID: 14764731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
    Miller TW; Amason JD; Garcin ED; Lamy L; Dranchak PK; Macarthur R; Braisted J; Rubin JS; Burgess TL; Farrell CL; Roberts DD; Inglese J
    PLoS One; 2019; 14(7):e0218897. PubMed ID: 31276567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD47 functions as a molecular switch for erythrocyte phagocytosis.
    Burger P; Hilarius-Stokman P; de Korte D; van den Berg TK; van Bruggen R
    Blood; 2012 Jun; 119(23):5512-21. PubMed ID: 22427202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophages show higher levels of engulfment after disruption of
    Hayes BH; Tsai RK; Dooling LJ; Kadu S; Lee JY; Pantano D; Rodriguez PL; Subramanian S; Shin JW; Discher DE
    J Cell Sci; 2020 Mar; 133(5):. PubMed ID: 31964705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis.
    Zhang W; Huang Q; Xiao W; Zhao Y; Pi J; Xu H; Zhao H; Xu J; Evans CE; Jin H
    Front Immunol; 2020; 11():18. PubMed ID: 32082311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding Mechanism of CD47 with SIRPα Variants and Its Antibody: Elucidated by Molecular Dynamics Simulations.
    Huang K; Liu Y; Wen S; Zhao Y; Ding H; Liu H; Kong DX
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial CD47 interaction with SIRPgamma is required for human T-cell transendothelial migration under shear flow conditions in vitro.
    Blood; ; . PubMed ID: 18524990
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.